We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGS icon
1826
Natural Gas Services Group
NGS
$469M
$336K ﹤0.01%
20,876
+1,050
+5% +$15.2K
COOP
1827
DELISTED
Mr. Cooper
COOP
$336K ﹤0.01%
+5,153
New +$305K
ACLS icon
1828
Axcelis
ACLS
$3.94B
$336K ﹤0.01%
+2,587
New +$357K
VTSI icon
1829
VirTra
VTSI
$35.5M
$335K ﹤0.01%
35,356
-19,618
-36% -$128K
FRDM icon
1830
Freedom 100 Emerging Markets ETF
FRDM
$3.25B
$333K ﹤0.01%
+10,125
New +$306K
SDSTW
1831
CALL
Stardust Power Inc Warrant
SDSTW
$4.56M
$332K ﹤0.01%
30,000
-89,698
-75% -$3.53K
RMTI icon
1832
Rockwell Medical
RMTI
$27.6M
$331K ﹤0.01%
17,510
-6,680
-28% -$125K
NOTV
1833
DELISTED
Inotiv
NOTV
$331K ﹤0.01%
90,147
+69,637
+340% +$176K
CRBU icon
1834
Caribou Biosciences
CRBU
$158M
$331K ﹤0.01%
+57,730
New +$285K
MGEE icon
1835
MGE Energy Inc
MGEE
$3.08B
$330K ﹤0.01%
+4,566
New +$330K
PLSE icon
1836
Pulse Biosciences
PLSE
$2.27B
$325K ﹤0.01%
+26,532
New +$184K
CLB icon
1837
Core Laboratories
CLB
$518M
$324K ﹤0.01%
+18,361
New +$370K
INTA icon
1838
Intapp
INTA
$2.27B
$323K ﹤0.01%
8,500
-265,955
-97% -$9.79M
CNSL
1839
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$323K ﹤0.01%
+74,200
New +$307K
GMM icon
1840
Global Mofy Metaverse
GMM
$5.27M
$323K ﹤0.01%
+77
New +$624K
EPAC icon
1841
Enerpac Tool Group
EPAC
$1.78B
$322K ﹤0.01%
+10,350
New +$295K
LPL icon
1842
LG Display
LPL
$3.14B
$321K ﹤0.01%
+66,617
New +$318K
LCID icon
1843
Lucid Motors
LCID
$2.54B
$320K ﹤0.01%
+7,596
New +$341K
SCS
1844
DELISTED
Steelcase
SCS
$319K ﹤0.01%
23,631
-380,512
-94% -$4.51M
PSNL icon
1845
Personalis
PSNL
$1.28B
$319K ﹤0.01%
+151,681
New +$196K
PSMT icon
1846
Pricesmart
PSMT
$5.81B
$317K ﹤0.01%
+4,181
New +$297K
ZCARW
1847
CALL
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$314K ﹤0.01%
84,968
MAG
1848
DELISTED
MAG Silver
MAG
$313K ﹤0.01%
30,072
-210,493
-87% -$2.25M
IHF icon
1849
iShares US Healthcare Providers ETF
IHF
$1.21B
$313K ﹤0.01%
5,960
+840
+16% +$42.6K
CNTY icon
1850
Century Casinos
CNTY
$32.6M
$312K ﹤0.01%
63,921
+4,561
+8% +$21.1K

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.